Deep Brain Stimulator

Deep Brain Stimulation Technologies (DBST), a 2019-spinoff of the Bionics Institute of Australia, an internationally recognized and independent medical research institute, was established to further develop and commercialize deep brain stimulation technology. Their goal was to create an implantable neurostimulator device capable of delivering personalized stimulation patterns and recording neural activity. This groundbreaking innovation aims to improve the lives of patients with Parkinson's disease and other movement disorders who no longer benefit from conventional medication. A topic recently discussed by our own expert in the field.

DBST’s neurostimulator device stands out for its versatility in stimulation patterns, offering a flexible generation of customizable electrical pulses. However, what sets it apart is its ability not only to stimulate but also to record neural activity. The onboard processing power allows for the analysis of these recordings, enabling the adjustment of stimulation patterns tailored to each patient's needs.

The ability to customize stimulation patterns provides several advantages. By minimizing the body's habituation response, long-term efficiency is improved, and side effects are reduced. This smart device learns from its user, ensuring optimal therapeutic outcomes. It is primarily designed for patients experiencing significant movement dysfunction that disrupts their daily lives, making it difficult for them to perform even simple tasks. With the neurostimulator, these patients can regain their independence and resume activities they were previously unable to engage in. Which really shows how great engineering can truly change lives.

As their engineering partner, we designed and developed the electronics, wrote the software, and oversaw the production of the neurostimulator device. It was a challenge to efficiently and comfortably integrate inductive battery charging and all three functions (stimulation, recording, and processing) into the limited space available in the implant. In the end, we were able to develop a smart device, fully in line with DBST’s requirements and fulfilling their goal to provide long-term efficiency and comfort for their patients.

The development of the neurostimulator device is nearing completion, enabling transition to the production of devices for implantation in a limited number of trial participants. Rigorous testing ensures that the devices meet the necessary standards for use in clinical trials. Industrialization will remain focused on low-volume production, as the main objective is continued research.

Deep Brain Stimulation Technologies has already secured several research grants in Australia, underscoring their commitment to ongoing research to enhance therapy. Their efforts have yielded an innovative solution that holds the potential to transform the field of deep brain stimulation and improve the lives of countless patients worldwide.